Clinical differences between resistant hypertensives and patients treated and controlled with three or less drugs

Journal of Hypertension

Volumn 30, Issue 6, 2012, Pages 1211-1216

  De La Sierra, Alejandro ^a   Banegas, José R ^b   Oliveras, Anna ^c   Gorostidi, Manuel ^d   Segura, Julián ^e   De La Cruz, Juan J ^b   Armario, Pedro ^f   Ruilope, Luis M ^e  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^e HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^f HOSPITAL GENERAL DE CATALUNYA   (Spain)

Author keywords

ambulatory blood pressure monitoring; masked hypertension; resistant hypertension; target organ damage; white coat hypertension

Indexed keywords

ABDOMINAL OBESITY; ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL EVALUATION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GLOMERULUS FILTRATION RATE; HEART INJURY; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; OBESITY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RESISTANT HYPERTENSION;

EID: 84861095815     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328353634e     Document Type: Article

References (16)

1. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: diagnosis, evaluation and treatment: a scientific statement from the American Heart Association Professional Education Committee of The Council for High Blood Pressure Research. Hypertension 2008; 51:1403-1419.
2. De la Sierra A, Segura J, Banegas JR, Gorostidi M, de la Cruz JJ, Armario P, Ruilope LM. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension 2011; 57:898-902.
3. Persell SD. Prevalence of resistant hypertension in the United States, 2003-2008. Hypertension 2011; 57:1076-1080.
4. Salles GF, Cardoso CRL, Muxfeldt ES. Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Arch Intern Med 2008; 168:2340-2346.
5. Oliveras A, Armario P, Hernandez-del Rey R, Arroyo JA, Poch E, Larrousse M, et al. Urinary albumin excretion is associated with true resistant hypertension. J Hum Hypertens 2010; 24:27-33.
6. Oliveras A, Armario P, Martell N, Ruilope LM, De la Sierra A. Urinary albumin excretion is associated with nocturnal systolic blood pressure in resistant hypertensives. Hypertension 2011; 57:556-560.
7. Cuspidi C, Macca G, Sampieri L, Michev I, Salerno M, Fusi V, et al. High prevalence of cardiac and extracardiac target organ damage in refractory hypertension. J Hypertens 2001; 19:2063-2070.
8. Lloyd-Jones DM, Evans JC, Larson MG, O'Donnell CJ, Rocella EJ, Levy D. Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community. Hypertension 2000; 36:594-599.
9. Egan BM, Zhao Y, Axon N, Brzezinski WA, Ferdinand KC. Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation 2011; 124:1046-1058.
10. Banegas JR, Segura J, Sobrino J, Rodríguez-Artalejo F, De La Sierra A, De La Cruz JJ, et al. Effectiveness of blood pressure control outside the medical setting. Hypertension 2007; 49:62-68.
11. De la Sierra A, Redon J, Banegas JR, Segura J, Parati G, Gorostidi M, et al. Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension 2009; 53:466-472.
12. De la Sierra A, Gorostidi M, Marin R, Redon J, Banegas JR, Armario P, et al. Evaluation and management of hypertension in Spain. A consensus guide [article in Spanish]. Med Clin (Barc) 2008; 131:104-116.
13. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105-1187.
14. Gupta AK, Nasothimiou EG, Chang CL, Sever PS, Dahlöf B, Poulter NR. Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk. J Hypertens 2011; 29:2004-2013.
15. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 2003; 348:2407-2415.
16. Bobrie G, Clerson P, Ménard J, Postel-Vinay N, Chatellier G, Plouin PF. Masked hypertension: a systematic review. J Hypertens 2008; 26:1715-1725.